Issue 8, 2015
From the journal:

MedChemComm

Correction: Identification of a novel class of autotaxin inhibitors through cross-screening

Diana Castagna,a   Emma L. Duffy,a   Dima Semaan,b   Louise C. Young,b   John M. Pritchard,c   Simon J. F. Macdonald,c   David C. Budd,c   Craig Jamieson*a  and  Allan J. B. Watson*a  

* Corresponding authors

a WestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building, 295 Cathedral Street, Glasgow, UK
E-mail: craig.jamieson@strath.ac.uk, allan.watson.100@strath.ac.uk

b Strathclyde Institute of Pharmacy and Biomolecular Science, University of Strathclyde, John Arbuthnott Building (Hamnett Wing), 161 Cathedral Street, Glasgow, UK

c Fibrosis DPU, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, UK

Abstract

Correction for ‘Identification of a novel class of autotaxin inhibitors through cross-screening’ by Diana Castagna et al., Med. Chem. Commun., 2015, 6, 1149–1155.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C5MD90032H
Article type
Correction
Submitted
26 Jun 2015
Accepted
26 Jun 2015
First published
07 Jul 2015
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2015,6, 1575-1575

Permissions

Request permissions

Correction: Identification of a novel class of autotaxin inhibitors through cross-screening

D. Castagna, E. L. Duffy, D. Semaan, L. C. Young, J. M. Pritchard, S. J. F. Macdonald, D. C. Budd, C. Jamieson and A. J. B. Watson, Med. Chem. Commun., 2015, 6, 1575 DOI: 10.1039/C5MD90032H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements